In cohort 1, the HS values of EGFR, KRAS, HER2, BRAF, and PIK3CA were calculated to estimate intratumor genetic heterogeneity in lung adenocarcinoma. This evidence concerns the gene ERBB2 and lung adenocarcinoma.